Aspen Pharmacare Holdings Ltd
JSE:APN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
|
N
|
NVR Inc
F:NVE
|
US |
Intrinsic Value
The intrinsic value of Aspen Pharmacare Holdings Ltd (APN) under the Base Case is 9 936.88 Zac per share. Compared with the current market price of 15 594 Zac, the stock appears Overvalued by 36% .
The intrinsic value is calculated using the DCF method. The model assumes revenue returns to growth: about 7% a year over the next five years, after falling about 2% a year over the last five years. If revenue grew at its five-year pace of -2%, the estimate would be about Zac 7,229.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Aspen Pharmacare Does
Aspen Pharmacare is a pharmaceutical company that makes and sells medicines, mainly branded and generic prescription drugs, injectables, and other hospital-focused products. It also has manufacturing capabilities that support third-party production in some cases. The company serves pharmacies, hospitals, governments, wholesalers, and other healthcare buyers that need reliable supply of essential medicines.
- Headquarters
- South Africa ZA
- Employees
- 9 128
- IPO date
- Dec 5, 1994
Earnings Waterfall
Aspen Pharmacare Holdings Ltd
The intrinsic value for Aspen Pharmacare Holdings Ltd (APN) under the Base Case is 9 936.88 Zac.
Compared with the current market price of 15 594 Zac, the stock appears Overvalued by 36% .